Invention Grant
US08937099B2 N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
有权
N-乙酰半胱氨酸酰胺（NAC酰胺），用于治疗与氧化应激相关的疾病和病症
- Patent Title: N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
- Patent Title (中): N-乙酰半胱氨酸酰胺（NAC酰胺），用于治疗与氧化应激相关的疾病和病症
-
Application No.: US12707092Application Date: 2010-02-17
-
Publication No.: US08937099B2Publication Date: 2015-01-20
- Inventor: Glenn A. Goldstein
- Applicant: Glenn A. Goldstein
- Applicant Address: US NY New York
- Assignee: Sentient Lifesciences, Inc.
- Current Assignee: Sentient Lifesciences, Inc.
- Current Assignee Address: US NY New York
- Agency: Lathrop & Gage LLP
- Main IPC: A01N37/12
- IPC: A01N37/12 ; A01N37/44 ; A61K31/16 ; C07C233/18 ; C07C233/36 ; C07C323/41 ; C07C323/60
Abstract:
Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
Public/Granted literature
Information query
IPC分类:
